XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2016
Apr. 30, 2016
Current Assets:    
Cash and cash equivalents $ 7,579 $ 5,222
Restricted cash 1,649 1,567
Receivables, less allowance: $225, $202, on each respective date 29,040 27,835
Inventories 16,789 15,626
Prepaid expenses and other current assets 1,023 707
Total Current Assets 56,080 50,957
Property, plant and equipment, at cost 51,630 49,928
Accumulated depreciation (37,051) (35,810)
Net Property, Plant and Equipment 14,579 14,118
Deferred income taxes 3,436 3,392
Other 3,459 3,938
Total Other Assets 6,895 7,330
Total Assets 77,554 72,405
Current Liabilities:    
Short-term borrowings and interest rate swaps 6,722 3,818
Current portion of long-term debt 421 421
Accounts payable 10,821 11,722
Employee compensation and amounts withheld 2,605 2,333
Deferred revenue 1,115 785
Other accrued expenses 2,956 1,871
Total Current Liabilities 24,640 20,950
Long-term debt 3,139 3,349
Accrued pension and deferred compensation costs 9,026 9,554
Total Liabilities 36,805 33,853
Commitments and Contingencies
Stockholders' Equity:    
Common Stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,713; 2,688 shares; - Outstanding - 2,710 shares; 2,685 shares, on each respective date 6,783 6,720
Additional paid-in-capital 2,551 2,375
Retained earnings 38,855 36,826
Accumulated other comprehensive loss (7,777) (7,626)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 40,359 38,242
Noncontrolling interest 390 310
Total Equity 40,749 38,552
Total Liabilities and Equity $ 77,554 $ 72,405